Vanguard Capital Management
BDSX icon

Vanguard Capital Management’s Biodesix BDSX Stock Holding History

Vanguard Capital Management’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.41M Buy
284,169
+29,008
+11% +$430K ﹤0.01% 3028
2026
Q1 		$3.7M Buy
+255,161
New +$3.16M ﹤0.01% 3169

Other funds holding BDSX

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.38B AUM 71.45% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.21B AUM 82.36% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Vanguard Capital Management's BDSX Position: Q2 2026 in Review

Vanguard Capital Management increased its Biodesix (BDSX) stake by 11% in Q2 2026, buying an estimated $430K and bringing the position to 284,169 shares worth $6.41M. The position accounts for ﹤0.01% of the portfolio, ranked #3028.

Vanguard Capital Management first reported a position in BDSX in Q1 2026 and has held it in 2 quarters since. 39 funds tracked by Wall St. Rank hold BDSX as of Q2 2026.

  • Vanguard Capital Management held 284,169 shares of Biodesix worth $6.41M as of Q2 2026.
  • Vanguard Capital Management bought 29,008 Biodesix shares in Q2 2026, an estimated $430K.
  • Biodesix made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #3028 holding.
  • Vanguard Capital Management first reported a position in Biodesix in Q1 2026 and has held it in 2 quarters since.
  • 39 funds tracked by Wall St. Rank held Biodesix as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.